Home›Companies›Biotech & Pharma›Nanochon

Nanochon, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 5, 2026·Suggest an edit

About Nanochon

Nanochon is a private company based in Washington, District of Columbia, incorporated in 2021 in Delaware. It has reported $9,579,592 raised in three offerings on Form D since October 2021. Its chief executive is Benjamin Holmes.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 24, 2025Feb 5, 2026$3,582,315of $4.2M target39$91,854Equity, OptionsRule 506(b)Form D ↗
Aug 15, 2023Aug 28, 2023amended May 15, 2024$3,991,279of $6.0M target34$117KEquityRule 506(b)Form D/A ↗1 earlier filing
Sep 16, 2021Oct 1, 2021$2,005,998of $2.5M target17$117KEquityRule 506(b)Form D ↗
Total, three offerings$9,579,592

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nanochon's Form D filed Feb 5, 2026.

BH
Benjamin Holmes
Chief Executive Officer and director
NP
Nick Pachuda
Director
KJ
Kurt Jacobus
Director
Also a director at Codoxo and CurvaFix and a chairman of the board at EarliPoint Health.
RC
SC

Earlier filings also listed Greg Horner (director, last listed May 2024) and Nathan Castro (executive officer and director, last listed Oct 2021).

Sources

  1. SECNanochon, Inc. Form D, filed Aug 28, 2023
  2. SECNanochon, Inc. filing history